BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22104997)

  • 21. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombus formation on the Amplatzer device: a need for critical attitude in percutaneous patent ovale closure decision-making.
    Ciurus T; Piestrzeniewicz K; Maciejewski M; Łuczak K; Jakubowski P; Drożdż J
    Eur Heart J; 2015 May; 36(19):1195. PubMed ID: 25433024
    [No Abstract]   [Full Text] [Related]  

  • 23. Silent embolization of an Amplatzer atrial septal closure device into the main pulmonary artery: pivotal role of routine postprocedural surveillance echocardiography.
    Duygu H; Akyildiz ZI; Kocabas U; Nazli C; Ergene O
    Int J Cardiol; 2011 Apr; 148(2):235-7. PubMed ID: 19896226
    [No Abstract]   [Full Text] [Related]  

  • 24. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
    Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell A; Wilson N; Ormerod O
    Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ; Hagler DJ; Taggart NW
    Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure.
    Scacciatella P; Biava LM; Marra S
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):494-6. PubMed ID: 24399577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical management of embolized Amplatzer septal occluder into the left ventricle tangled with the mitral valve.
    Martínez-Comendador J; Martín E; Gualis J; Castaño M
    J Card Surg; 2020 Jul; 35(7):1687-1689. PubMed ID: 32400072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration of an embolized patent foramen ovale closure device to the left ventricular outflow tract.
    MacKnight BM; Stearns JD; Vricella LA; Resar JR
    Anesth Analg; 2007 Nov; 105(5):1229-30. PubMed ID: 17959947
    [No Abstract]   [Full Text] [Related]  

  • 29. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
    Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
    EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical rescue of embolized amplatzer septal occluder.
    Cianciulli TF; Redruello HJ; Rubio MA; Poveda Camargo RL; Granja MA; Barrero CM; Mauro VM
    Can J Cardiol; 2014 Apr; 30(4):465.e3-4. PubMed ID: 24518660
    [No Abstract]   [Full Text] [Related]  

  • 31. Foreign body granuloma as an unexpected long-term finding after percutaneous closure of a patent foramen ovale.
    Besler C; Bakhtiary F; Linke A; Zimmer M
    Eur Heart J; 2017 Dec; 38(46):3472-3473. PubMed ID: 28369276
    [No Abstract]   [Full Text] [Related]  

  • 32. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
    Siddiqui IF; Michaels AD
    J Interv Cardiol; 2011 Jun; 24(3):271-7. PubMed ID: 21114532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).
    Taaffe M; Fischer E; Baranowski A; Majunke N; Heinisch C; Leetz M; Hein R; Bayard Y; Büscheck F; Reschke M; Hoffmann I; Wunderlich N; Wilson N; Sievert H
    Am J Cardiol; 2008 May; 101(9):1353-8. PubMed ID: 18435971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Snares for embolized septal occluders: retrieval of tangled, twisted, and mangled devices in structural heart intervention.
    Feldman T
    Catheter Cardiovasc Interv; 2011 May; 77(6):901-2. PubMed ID: 21520388
    [No Abstract]   [Full Text] [Related]  

  • 35. Percutaneous retrieval of an Amplatzer septal occluder device that had migrated to the aortic arch.
    Guimaraes M; Denton CE; Uflacker R; Schonholz C; Selby B; Hannegan C
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):430-3. PubMed ID: 21431972
    [No Abstract]   [Full Text] [Related]  

  • 36. Incomplete endothelialization and late dislocation after implantation of an Amplatzer septal occluder device.
    Chen F; Zhao X; Zheng X; Chen S; Xu R; Qin Y
    Circulation; 2011 Aug; 124(6):e188-9. PubMed ID: 21824928
    [No Abstract]   [Full Text] [Related]  

  • 37. Amplatzer® septal occluder device early embolization to left ventricular outflow tract in asymptomatic patient.
    Vizzari G; Pizzino F; Bajwa T; Ammar KA; Khandheria BK
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):925. PubMed ID: 24682957
    [No Abstract]   [Full Text] [Related]  

  • 38. Interventional radiological retrieval of embolized vascular access device fragments.
    Önal B; Coşkun B; Karabulut R; Ilgıt ET; Türkyilmaz Z; Sönmez K
    Diagn Interv Radiol; 2012; 18(1):87-91. PubMed ID: 21305467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embolization of percutaneous closure device.
    Maguire D; Shah A; Kass M
    Can J Anaesth; 2019 Aug; 66(8):987-988. PubMed ID: 30972692
    [No Abstract]   [Full Text] [Related]  

  • 40. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.